Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop

Go back to Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop
(NASDAQ: EVAX) Delayed: 3.05 +0.01 (0.33%)
Previous Close $3.04    52 Week High
Open $3.02    52 Week Low
Day High $3.15    P/E N/A 
Day Low $2.96    EPS
Volume 10,386